PortalPublikationenAssociation of perioperative blood transfusion with oncologi...

Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma

Standard

Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. / Rieken, M; Schubert, T; Xylinas, E; Kluth, L; Rouprêt, M; Trinh, Q-D; Lee, R K; Al Hussein Al Awamlh, B; Fajkovic, H; Novara, G; Margulis, V; Lotan, Y; Martinez-Salamanca, J I; Matsumoto, K; Seitz, C; Remzi, M; Karakiewicz, P I; Scherr, D S; Briganti, A; Bachmann, A; Shariat, S F; UTUC Collaboration.

in: EJSO-EUR J SURG ONC, Jahrgang 40, Nr. 12, 01.12.2014, S. 1693-1699.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Rieken, M, Schubert, T, Xylinas, E, Kluth, L, Rouprêt, M, Trinh, Q-D, Lee, RK, Al Hussein Al Awamlh, B, Fajkovic, H, Novara, G, Margulis, V, Lotan, Y, Martinez-Salamanca, JI, Matsumoto, K, Seitz, C, Remzi, M, Karakiewicz, PI, Scherr, DS, Briganti, A, Bachmann, A, Shariat, SF & UTUC Collaboration 2014, 'Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma', EJSO-EUR J SURG ONC, Jg. 40, Nr. 12, S. 1693-1699. https://doi.org/10.1016/j.ejso.2014.03.018

APA

Rieken, M., Schubert, T., Xylinas, E., Kluth, L., Rouprêt, M., Trinh, Q-D., Lee, R. K., Al Hussein Al Awamlh, B., Fajkovic, H., Novara, G., Margulis, V., Lotan, Y., Martinez-Salamanca, J. I., Matsumoto, K., Seitz, C., Remzi, M., Karakiewicz, P. I., Scherr, D. S., Briganti, A., ... UTUC Collaboration (2014). Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. EJSO-EUR J SURG ONC, 40(12), 1693-1699. https://doi.org/10.1016/j.ejso.2014.03.018

Vancouver

Rieken M, Schubert T, Xylinas E, Kluth L, Rouprêt M, Trinh Q-D et al. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. EJSO-EUR J SURG ONC. 2014 Dez 1;40(12):1693-1699. https://doi.org/10.1016/j.ejso.2014.03.018

Bibtex

@article{6bc2a08409de4abe8cf8a56217340f80,
title = "Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma",
abstract = "BACKGROUND: To test the hypothesis that perioperative blood transfusion (PBT)impacts oncologic outcomes of patients treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).METHODS: Retrospective analysis of 2492 patients with UTUC treated at 23 institutions with RNU between 1987 and 2007.Cox regression models addressed the association of PBT with disease recurrence, cancer-specific mortality and any-cause mortality.RESULTS: A total of 510 patients (20.5%) patients received PBT. Within a median follow-up of 36 months (Interquartile range: 55 months), 663 (26.6%) patients experienced disease recurrence, 545 patients (21.9%) died of UTUC and 884 (35.5%) patients died from any cause. Patients who received PBT were at significantly higher risk of disease recurrence, cancer-specific mortality and overall mortality than patients not receiving PBT in univariable Cox regression analyses. In multivariable Cox regression analyses that adjusted for the effects of standard clinicopathologic features, PBT did not remain associated with disease recurrence (HR: 1.11; 95% CI 0.92-1.33, p = 0.25), cancer-specific mortality (HR: 1.09; 95% CI 0.89-1.33, p = 0.41) or overall mortality (HR: 1.09; 95% CI 0.93-1.28, p = 0.29).CONCLUSIONS: In patients undergoing RNU for UTUC, PBT is associated with disease recurrence, cancer-specific survival or overall survival in univariable, but not in multivariable Cox regression analyses.",
author = "M Rieken and T Schubert and E Xylinas and L Kluth and M Roupr{\^e}t and Q-D Trinh and Lee, {R K} and {Al Hussein Al Awamlh}, B and H Fajkovic and G Novara and V Margulis and Y Lotan and Martinez-Salamanca, {J I} and K Matsumoto and C Seitz and M Remzi and Karakiewicz, {P I} and Scherr, {D S} and A Briganti and A Bachmann and Shariat, {S F} and {UTUC Collaboration}",
note = "Copyright {\textcopyright} 2014 Elsevier Ltd. All rights reserved.",
year = "2014",
month = dec,
day = "1",
doi = "10.1016/j.ejso.2014.03.018",
language = "English",
volume = "40",
pages = "1693--1699",
journal = "EJSO-EUR J SURG ONC",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "12",

}

RIS

TY - JOUR

T1 - Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma

AU - Rieken, M

AU - Schubert, T

AU - Xylinas, E

AU - Kluth, L

AU - Rouprêt, M

AU - Trinh, Q-D

AU - Lee, R K

AU - Al Hussein Al Awamlh, B

AU - Fajkovic, H

AU - Novara, G

AU - Margulis, V

AU - Lotan, Y

AU - Martinez-Salamanca, J I

AU - Matsumoto, K

AU - Seitz, C

AU - Remzi, M

AU - Karakiewicz, P I

AU - Scherr, D S

AU - Briganti, A

AU - Bachmann, A

AU - Shariat, S F

AU - UTUC Collaboration

N1 - Copyright © 2014 Elsevier Ltd. All rights reserved.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - BACKGROUND: To test the hypothesis that perioperative blood transfusion (PBT)impacts oncologic outcomes of patients treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).METHODS: Retrospective analysis of 2492 patients with UTUC treated at 23 institutions with RNU between 1987 and 2007.Cox regression models addressed the association of PBT with disease recurrence, cancer-specific mortality and any-cause mortality.RESULTS: A total of 510 patients (20.5%) patients received PBT. Within a median follow-up of 36 months (Interquartile range: 55 months), 663 (26.6%) patients experienced disease recurrence, 545 patients (21.9%) died of UTUC and 884 (35.5%) patients died from any cause. Patients who received PBT were at significantly higher risk of disease recurrence, cancer-specific mortality and overall mortality than patients not receiving PBT in univariable Cox regression analyses. In multivariable Cox regression analyses that adjusted for the effects of standard clinicopathologic features, PBT did not remain associated with disease recurrence (HR: 1.11; 95% CI 0.92-1.33, p = 0.25), cancer-specific mortality (HR: 1.09; 95% CI 0.89-1.33, p = 0.41) or overall mortality (HR: 1.09; 95% CI 0.93-1.28, p = 0.29).CONCLUSIONS: In patients undergoing RNU for UTUC, PBT is associated with disease recurrence, cancer-specific survival or overall survival in univariable, but not in multivariable Cox regression analyses.

AB - BACKGROUND: To test the hypothesis that perioperative blood transfusion (PBT)impacts oncologic outcomes of patients treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).METHODS: Retrospective analysis of 2492 patients with UTUC treated at 23 institutions with RNU between 1987 and 2007.Cox regression models addressed the association of PBT with disease recurrence, cancer-specific mortality and any-cause mortality.RESULTS: A total of 510 patients (20.5%) patients received PBT. Within a median follow-up of 36 months (Interquartile range: 55 months), 663 (26.6%) patients experienced disease recurrence, 545 patients (21.9%) died of UTUC and 884 (35.5%) patients died from any cause. Patients who received PBT were at significantly higher risk of disease recurrence, cancer-specific mortality and overall mortality than patients not receiving PBT in univariable Cox regression analyses. In multivariable Cox regression analyses that adjusted for the effects of standard clinicopathologic features, PBT did not remain associated with disease recurrence (HR: 1.11; 95% CI 0.92-1.33, p = 0.25), cancer-specific mortality (HR: 1.09; 95% CI 0.89-1.33, p = 0.41) or overall mortality (HR: 1.09; 95% CI 0.93-1.28, p = 0.29).CONCLUSIONS: In patients undergoing RNU for UTUC, PBT is associated with disease recurrence, cancer-specific survival or overall survival in univariable, but not in multivariable Cox regression analyses.

U2 - 10.1016/j.ejso.2014.03.018

DO - 10.1016/j.ejso.2014.03.018

M3 - SCORING: Journal article

C2 - 24780094

VL - 40

SP - 1693

EP - 1699

JO - EJSO-EUR J SURG ONC

JF - EJSO-EUR J SURG ONC

SN - 0748-7983

IS - 12

ER -